FOR PATIENTS

This study presents a method for treating wound infections that has never been done before, but is a concept that makes sense and is easy to understand. A simple way to convey how the process works would be to use the following analogy: If there is a fly in the room, there are two ways to kill it: 1) use a flyswatter; or 2) fumigate the entire room. Traditional methods for treating cellulitis and MRSA infections have been to "fumigate" the entire body with antibiotics that are often toxic to the system (e.g., Vancomycin) and can have detrimental side effects. The method presented here offers a way to treat the infection at its source by infusing a Cephalosporin antibiotic (primarily Cefazolin) into the target tissue at the wound site and disperse it with external ultrasound. Cephalosporin antibiotics are generally well-tolerated and non-toxic at the levels used for this procedure. In fact, the national Surgical Care Improvement Project (SCIP) mandates administration of a Cephalosporin antibiotics, prophylactically, one hour prior to undergoing surgery. (Note: an exception was made to this SCIP measure to accommodate our clinical trials.) .

This treatment works completely independent of blood supply, which is of particular importance to those with impaired circulation, such as people with diabetes. Poor blood supply presents a condition that further reduces the efficacy of traditional IV treatment since it limits the amount of antibiotic that can reach the target area.

From June through December, 2011, over 75 patients have been successfully treated at Santa Rosa Memorial Hospital. Each treatment takes approximately 15 minutes and the need for more than one treatment has been rare. No negative side effects have been reported. Details on the procedure can be found here. Case studies with before and after photos can be viewed here, but be forewarned that some of the images are graphic.

If you, or anyone you know, is suffering from a chronic wound infection, you may contact us at info@antibioticresearch.org for further information. This procedure is currently approved for off-label use only at Santa Rosa Memorial Hospital, Santa Rosa, California, and qualifying patients must sign a consent for treatment.

©2008 Santa Rosa Antibiotic Effectiveness Research Project, Inc.
P. O. Box 1244 | Santa Rosa, CA 95402 | (707) 568-3005 - Tel/Fax